Research on Co-Opetition Mechanism between Pharmaceutical Enterprises and Third-Party Logistics in Drug Distribution of Medical Community

Author:

Li Zhao,Xia TieORCID,Shen Wanzhi,Chen Sheng

Abstract

Third-party logistics (3PL) has a relatively perfect distribution system in solving the drug distribution of the medical community and optimizing the distribution efficiency of pharmaceutical enterprises, and it has gradually become an indispensable component of drug distribution. By constructing the co-opetition model of “Pharmaceutical Enterprises—3PL”, this paper explores the game strategy choice between pharmaceutical enterprises and 3PL for the solution of drug distribution under the condition of information asymmetry, and it puts forward some suggestions to improve the competition and cooperation mechanism between pharmaceutical enterprises and 3PL in drug distribution in the medical community.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

General Project of Social Science Foundation of Jiangsu Province

National Natural Youth Science Foundation of China

Postdoctoral Research Funding Program of Jiangsu Province

Jiangsu University Philosophy and Social Science Research Fund

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference35 articles.

1. Expert consensus on the regulation of pharmaceutical affairs management and pharmaceutical care in China’s county medical community;Dai;Chin. J. Mod. Appl. Pharm.,2021

2. Promoting healthy village construction: Challenges and countermeasures;Shi;Strateg. Study Chin. Acad. Eng.,2021

3. The State Council of The People’s Republic of China (2022, October 12). The State Council Printed and Distributed the Decision on the Second Batch of Cancellation of 152 Items of Administrative Examination and Approval Implemented by Central Designated Places, Available online: http://www.gov.cn/xinwen/2016-02/19/content_5043935.htm.

4. The State Council of The People’s Republic of China (2022, October 12). The General Office of the State Council Issued the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, Available online: http://www.gov.cn/xinwen/2016-03/11/content_5052336.htm.

5. National Health Commission of the People’s Republic of China (2022, December 20). A Circular on Promoting the Construction of a Compact County Medical and Health Community, Available online: http://www.gov.cn/zhengce/zhengceku/2019-10/08/content_5437020.htm.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3